Skip to main content

A Phase 2, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate Upadacitinib in Adult Subjects with Moderate to Severe Hidradenitis Suppurativa

Clinical Trial Grant
Duke Scholars

Administered By

Dermatology

Awarded By

AbbVie Inc.

Start Date

December 9, 2020

End Date

July 6, 2021
 

Administered By

Dermatology

Awarded By

AbbVie Inc.

Start Date

December 9, 2020

End Date

July 6, 2021